Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cachexia × Counseling × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 28 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Prostatic Neoplasms 8 Lung Neoplasms 8 Colorectal Neoplasms 8 Colonic Neoplasms 8 Motor Activity 7 Small Cell Lung Carcinoma 6 Rectal Neoplasms 6 Obesity 6 Endometrial Neoplasms 6 Uterine Cervical Neoplasms 5 Tobacco Use Disorder 5 Pancreatic Neoplasms 5 Overweight 5 Leukemia, Myeloid, Acute 5 Leukemia 4 Depression 4 Breast Carcinoma In Situ 4 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Sexuality 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 Fatigue 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Intraductal, Noninfiltrating 3

Interventions

Megestrol Acetate 7 Exercise 5 Standard of Care 4 Olanzapine 3 Blood Specimen Collection 3 dermcidin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Ibuprofen 2 Enteral Nutrition 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 bermekimab 1 anamorelin 1 Vitamin D 1 Ultrasonography 1 Retrospective Studies 1 Radiotherapy 1 Powders 1 Omacor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡